Step 1 topics → Biochemistry → Glycolysis (Pathway and ATP Yield)

Glycolysis (Pathway and ATP Yield)

USMLE Step 1 trap: Confuses gross ATP yield (4) with net ATP yield (2) in glycolysis. Glycolysis produces 4 ATP gross but only 2 ATP net because 2 ATP are consumed in the investment phase.

Glycolysis is the 10-step cytoplasmic pathway that converts one glucose into two pyruvate molecules. It runs in every cell, requires no oxygen, and is the exclusive ATP source for RBCs. USMLE Step 1 tests glycolysis from multiple angles: pure recall of yields and enzymes, mechanistic reasoning about kinetics and regulation, and clinical vignettes built around enzyme deficiencies or toxins. Students consistently confuse hexokinase (first enzyme) with PFK-1 (the actual rate-limiting enzyme), and report 4 ATP net yield instead of 2. The pathway splits into an investment phase (steps 1–5, consumes 2 ATP) and a payoff phase (steps 6–10, generates 4 ATP and 2 NADH), so net yield is 2 ATP and 2 NADH per glucose — not 4.

The trickiest part for most students is distinguishing between what happens first, what's rate-limiting, and what's irreversible. Hexokinase goes first, but PFK-1 controls the flux — it's the actual rate-limiting enzyme. This distinction shows up repeatedly on Step 1. Similarly, glucokinase and hexokinase both phosphorylate glucose but have completely different kinetic profiles and regulatory logic, and the exam loves to test which enzyme is in which tissue and why that matters physiologically.

Two clinical correlates round out the high-yield content: pyruvate kinase (PK) deficiency and arsenic toxicity. PK deficiency causes hemolytic anemia — not polycythemia — because RBCs have zero mitochondria and zero backup ATP source. Arsenic poisoning hits GAPDH-dependent substrate-level phosphorylation, not PFK-1, which is a detail the exam exploits in mechanism-based questions. If you can explain why each of these clinical findings makes sense from the pathway, you're in good shape.

From real student decks
95%have cards covering this topic
84%have mature cards
1median lapses in 14 days

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Glycolysis produces a net of 4 ATP per glucose.
Right: Glycolysis produces 4 ATP gross but only 2 ATP net because 2 ATP are consumed in the investment phase.
The 4 ATP figure is gross output from the payoff phase, but the investment phase burns 2 ATP to phosphorylate glucose and fructose-6-phosphate before any energy is recovered. Net yield is always gross minus investment: 4 − 2 = 2 ATP. When an exam question asks for glycolytic ATP yield, it virtually always means net, so defaulting to 4 will cost you points.
Common mistake
Wrong: Hexokinase is the rate-limiting enzyme of glycolysis because it is the first committed step.
Right: PFK-1 is the rate-limiting enzyme of glycolysis; hexokinase catalyzes the first step but is not rate-limiting.
Being first in a pathway does not make an enzyme rate-limiting — rate-limiting means the step that controls overall flux. PFK-1 sits at the committed, irreversible conversion of fructose-6-phosphate to fructose-1,6-bisphosphate and is exquisitely regulated by AMP (activates) and ATP/citrate (inhibits), making it the metabolic throttle of glycolysis. Hexokinase is inhibited by its own product (glucose-6-phosphate) and operates at a relatively fixed rate; it sets the entry point but doesn't control how fast the rest of the pathway runs.
Common mistake
Wrong: Pyruvate kinase deficiency causes polycythemia because RBCs cannot make ATP.
Right: Pyruvate kinase deficiency causes hemolytic anemia because RBCs rely entirely on glycolysis for ATP and cannot maintain membrane integrity without it.
RBCs are unique because they have no mitochondria, so they cannot run the TCA cycle or oxidative phosphorylation — glycolysis is their only ATP source, period. When pyruvate kinase is deficient, the final ATP-generating step of glycolysis fails, ATP drops, the Na⁺/K⁺-ATPase can't maintain membrane integrity, and RBCs lyse — producing hemolytic anemia. Polycythemia would imply increased RBCs, which is the opposite of what happens here.
Common mistake
Wrong: Arsenic inhibits glycolysis by blocking PFK-1 directly.
Right: Arsenic inhibits glycolysis by competing with phosphate in the GAPDH reaction, preventing substrate-level phosphorylation at that step and reducing net ATP yield.
Arsenic (as arsenate) is a phosphate analog that substitutes for inorganic phosphate in the GAPDH reaction, forming an unstable arsenate ester instead of the normal high-energy acyl-phosphate intermediate (1,3-BPG). This intermediate spontaneously hydrolyzes before it can donate its phosphate to ADP at the next step, so no ATP is made at that step. PFK-1 is unaffected; the damage is specifically to substrate-level phosphorylation at the GAPDH step, which reduces net ATP yield and explains the toxicity.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the exact net ATP and NADH yield of glycolysis (2 ATP net, 2 NADH), and be able to explain why gross yield (4 ATP) differs from net yield due to the 2 ATP consumed in the investment phase.
  2. Distinguish hexokinase from glucokinase: their Km values, saturation kinetics, tissue location (hexokinase in most tissues vs. glucokinase in liver and pancreatic β-cells), and how each is regulated (hexokinase is product-inhibited by glucose-6-phosphate; glucokinase is not).
  3. Identify the three irreversible steps of glycolysis (hexokinase, PFK-1, pyruvate kinase) and know that PFK-1 — not hexokinase — is the rate-limiting enzyme; understand what allosterically activates or inhibits PFK-1.
  4. Apply glycolytic biochemistry to clinical scenarios: pyruvate kinase deficiency causing hemolytic anemia in patients with no other source of ATP for RBCs, and arsenic poisoning impairing the GAPDH step to reduce net ATP yield through competitive inhibition of phosphate.

Can you avoid these mistakes?

A patient with chronic hemolytic anemia is found to have elevated 2,3-BPG levels in their RBCs. The enzyme upstream of 2,3-BPG production is normal. Which enzyme is most likely deficient, and what is the mechanism of hemolysis?
You're told that fructose-2,6-bisphosphate levels rise after a meal. Predict what happens to PFK-1 activity and explain why this makes physiological sense in the fed state.
Arsenic poisoning reduces net ATP yield from glycolysis without directly inhibiting PFK-1 or pyruvate kinase. Walk through which step is affected, why that intermediate is critical, and how many fewer ATP are produced per glucose.
A medical student claims glucokinase and hexokinase do the same thing, so it doesn't matter which one you test for in a hepatocyte. Give two specific reasons why this is wrong, focusing on Km and feedback regulation.

Related topics

Carbohydrate Structure and Digestion Nucleotide and Nucleic Acid Structure DNA Replication DNA Repair Pathways Mutations and Their Consequences

See how your Anki deck covers this topic.

Upload your deck for a free audit →